BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 21126161)

  • 1. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value.
    Noto Y; Shibuya K; Sato Y; Kanai K; Misawa S; Sawai S; Mori M; Uchiyama T; Isose S; Nasu S; Sekiguchi Y; Fujimaki Y; Kasai T; Tokuda T; Nakagawa M; Kuwabara S
    Amyotroph Lateral Scler; 2011 Mar; 12(2):140-3. PubMed ID: 21126161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential diagnosis of amyotrophic lateral sclerosis from Guillain-Barré syndrome by quantitative determination of TDP-43 in cerebrospinal fluid.
    Hosokawa M; Arai T; Yamashita M; Tsuji H; Nonaka T; Masuda-Suzukake M; Tamaoka A; Hasegawa M; Akiyama H
    Int J Neurosci; 2014 May; 124(5):344-9. PubMed ID: 24066851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Kasai T; Tokuda T; Ishigami N; Sasayama H; Foulds P; Mitchell DJ; Mann DM; Allsop D; Nakagawa M
    Acta Neuropathol; 2009 Jan; 117(1):55-62. PubMed ID: 18989684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS.
    Kasai T; Kojima Y; Ohmichi T; Tatebe H; Tsuji Y; Noto YI; Kitani-Morii F; Shinomoto M; Allsop D; Mizuno T; Tokuda T
    Ann Clin Transl Neurol; 2019 Dec; 6(12):2489-2502. PubMed ID: 31742901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Steinacker P; Hendrich C; Sperfeld AD; Jesse S; von Arnim CA; Lehnert S; Pabst A; Uttner I; Tumani H; Lee VM; Trojanowski JQ; Kretzschmar HA; Ludolph A; Neumann M; Otto M
    Arch Neurol; 2008 Nov; 65(11):1481-7. PubMed ID: 19001167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
    Gille B; De Schaepdryver M; Dedeene L; Goossens J; Claeys KG; Van Den Bosch L; Tournoy J; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1338-1346. PubMed ID: 31175169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TDP-43 as a potential biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Majumder V; Gregory JM; Barria MA; Green A; Pal S
    BMC Neurol; 2018 Jun; 18(1):90. PubMed ID: 29954341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis.
    Rossi D; Volanti P; Brambilla L; Colletti T; Spataro R; La Bella V
    J Neurol; 2018 Mar; 265(3):510-521. PubMed ID: 29322259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 as structure-based biomarker in amyotrophic lateral sclerosis.
    Beyer L; Günther R; Koch JC; Klebe S; Hagenacker T; Lingor P; Biesalski AS; Hermann A; Nabers A; Gold R; Tönges L; Gerwert K
    Ann Clin Transl Neurol; 2021 Jan; 8(1):271-277. PubMed ID: 33263951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF glial markers correlate with survival in amyotrophic lateral sclerosis.
    Süssmuth SD; Sperfeld AD; Hinz A; Brettschneider J; Endruhn S; Ludolph AC; Tumani H
    Neurology; 2010 Mar; 74(12):982-7. PubMed ID: 20308682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biomarkers for amyotrophic lateral sclerosis].
    Tokuda T
    Brain Nerve; 2012 May; 64(5):515-23. PubMed ID: 22570065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial ALS with G298S mutation in TARDBP: a comparison of CSF tau protein levels with those in sporadic ALS.
    Nozaki I; Arai M; Takahashi K; Hamaguchi T; Yoshikawa H; Muroishi T; Noguchi-Shinohara M; Ito H; Itokawa M; Akiyama H; Kawata A; Yamada M
    Intern Med; 2010; 49(12):1209-12. PubMed ID: 20558945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis.
    Scarafino A; D'Errico E; Introna A; Fraddosio A; Distaso E; Tempesta I; Morea A; Mastronardi A; Leante R; Ruggieri M; Mastrapasqua M; Simone IL
    J Neurol; 2018 Oct; 265(10):2353-2362. PubMed ID: 30116940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of inflammatory chemokines in amyotrophic lateral sclerosis.
    Kuhle J; Lindberg RL; Regeniter A; Mehling M; Steck AJ; Kappos L; Czaplinski A
    Eur J Neurol; 2009 Jun; 16(6):771-4. PubMed ID: 19236470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
    Riku Y; Watanabe H; Yoshida M; Tatsumi S; Mimuro M; Iwasaki Y; Katsuno M; Iguchi Y; Masuda M; Senda J; Ishigaki S; Udagawa T; Sobue G
    JAMA Neurol; 2014 Feb; 71(2):172-9. PubMed ID: 24378564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases.
    Feneberg E; Steinacker P; Lehnert S; Schneider A; Walther P; Thal DR; Linsenmeier M; Ludolph AC; Otto M
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):351-6. PubMed ID: 24834468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling TREM2 expression in amyotrophic lateral sclerosis.
    Jericó I; Vicuña-Urriza J; Blanco-Luquin I; Macias M; Martinez-Merino L; Roldán M; Rojas-Garcia R; Pagola-Lorz I; Carbayo A; De Luna N; Zelaya V; Mendioroz M
    Brain Behav Immun; 2023 Mar; 109():117-126. PubMed ID: 36681358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of potential CSF biomarkers in ALS.
    Pasinetti GM; Ungar LH; Lange DJ; Yemul S; Deng H; Yuan X; Brown RH; Cudkowicz ME; Newhall K; Peskind E; Marcus S; Ho L
    Neurology; 2006 Apr; 66(8):1218-22. PubMed ID: 16481598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure to ALS-FTD-CSF generates TDP-43 aggregates in glioblastoma cells through exosomes and TNTs-like structure.
    Ding X; Ma M; Teng J; Teng RK; Zhou S; Yin J; Fonkem E; Huang JH; Wu E; Wang X
    Oncotarget; 2015 Sep; 6(27):24178-91. PubMed ID: 26172304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.